40 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
that the reverse stock split, if implemented, will have the desired effect of raising the price of our common stock over the long term. The history of similar … to such fractional share of our common stock. Such capital gain or loss should be long-term capital gain or loss if the U.S. Holder’s holding period for our common
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
-time offer that we do not expect to offer again in the future. The price of shares of our Common Stock may not appreciate over the long term
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
, considered how to better align our employee and shareholder interests for long term shareholder return.
After careful consideration, we have decided
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
Expiration Date, what happens if my options end up underwater again?
The price of shares of our Common Stock may not appreciate over the long term
8-K
EX-99.1
fjhn4uxgzmcrxuiwe
2 Nov 23
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results
4:05pm
8-K
EX-10.1
z9q xbjs0
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-99.1
v3p27xfnp75l8wxq
2 Nov 22
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2022 Financial Results
4:05pm
8-K
EX-99.1
23on zdqx
4 Aug 22
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
6kmfocqf27n1ve
4 May 22
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2022 Financial Results
4:06pm